NYSE:BDXMedical Equipment
Becton Dickinson Refocuses On Medtech After Waters Spin Off And Buyback
Becton Dickinson (NYSE:BDX) has completed a $17.5b spin off and merger of its Biosciences and Diagnostic Solutions businesses with Waters.
The deal restructures Becton Dickinson as a more focused medtech company and is paired with a new capital allocation plan.
The company reported strong Q1 results alongside the announcement of a $2b share repurchase program and debt reduction plans.
Becton Dickinson, trading around $207.39, is reshaping itself around its core medtech operations after this...